Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is among the most common cancer diseases worldwide and has only limited treatment options at advanced disease stages. Activation of the immune system with checkpoint inhibitors has revolutionized cancer medicine and has become important also for HCC tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocker, Matthias, Mayr, Christian, Kiesslich, Tobias, Stintzing, Sebastian, Neureiter, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036419/
https://www.ncbi.nlm.nih.gov/pubmed/33805268
http://dx.doi.org/10.3390/cancers13071558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036419/
https://www.ncbi.nlm.nih.gov/pubmed/33805268
http://dx.doi.org/10.3390/cancers13071558

Ejemplares similares